Myoscience to Present at the Canaccord Genuity Musculoskeletal Conference


REDWOOD CITY, Calif., Feb. 25, 2014 (GLOBE NEWSWIRE) -- California based myoscience, inc., developers of the iovera°® system for the treatment of peripheral nerve conditions, announced today that Clint Carnell, Chairman and Chief Executive Officer, has been invited to make a presentation at the Canaccord Genuity Musculoskeletal Conference, which will be held on Tuesday, March 11, 2014 at 10:00 am CDT at the Sheraton New Orleans.

ABOUT MYOSCIENCE

Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold TherapyTM, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the patented technology delivered by the iovera° system. The iovera° system is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions, and is indicated in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com

The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13581

© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience.


            

Contact Data